France’s Rivercell emerges from stealth with €22 million for AI-powered drug discovery infrastructure
Paris-based Rivercell emerged from stealth with a €22m seed round led by HV, with HCVC, Alven and Bpifrance Digital Venture participating, to build AI-powered drug discovery infrastructure. It builds proprietary cell-response data and a predictive biological world model, relevant for deep-tech biotech founders seeking similar seed capital.